首页> 外国专利> Agent for prevention and depression of dry coughing caused by angiotensin converting enzyme inhibitors

Agent for prevention and depression of dry coughing caused by angiotensin converting enzyme inhibitors

机译:预防和抑制血管紧张素转化酶抑制剂引起的干咳的药物

摘要

The present invention is to provide an agent for the prevention and depression of dry coughing caused by angiotensin converting enzyme inhibitors which comprises a thromboxane synthetase inhibitor or thromboxane receptor antagonist as the active ingredient. Administering the drug is effective in preventing and depressing dry coughing caused by angiotensin converting enzyme inhibitors. For example, the use of the drug in combination with ozagrel hydrochloride was found to be effective in significantly dry coughing in hypertonic patients suffering from dry coughing attributable to the administration of captopril. IMAGE
机译:本发明提供了一种预防和抑制由血管紧张素转化酶抑制剂引起的干咳的药物,其包含血栓烷合成酶抑制剂或血栓烷受体拮抗剂作为活性成分。给药有效预防和抑制由血管紧张素转化酶抑制剂引起的干咳。例如,发现该药物与奥扎格雷盐酸盐的组合可有效治疗因卡托普利而引起干咳的高渗患者的明显干咳。 <图像>

著录项

  • 公开/公告号AU1110897A

    专利类型

  • 公开/公告日1997-07-14

    原文格式PDF

  • 申请/专利权人 KISSEI PHARMACEUTICAL CO. LTD.;

    申请/专利号AU19970011108

  • 发明设计人 KAZUO UMEMURA;MITSUYOSHI NAKASHIMA;

    申请日1996-12-13

  • 分类号A61K45/00;A61K31/415;

  • 国家 AU

  • 入库时间 2022-08-22 03:23:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号